Aaron M. Secrest
Rating: 4.9 of 5
( out of 46 reviews )

Aaron M. Secrest, MD, PhD, MBA

Languages spoken: English

  • Aaron Secrest, MD, PhD, MBA, is currently on a two-year sabbatical working as a senior medical officer in dermatology at Christchurch Hospital in New Zealand to experience a quality national healthcare system firsthand. He is temporarily stepping away from routine clinical care at Farmington Health Center and the University Hospital outpatient clinic. He will continue to staff Rapid Access Dermatology clinic (urgent care for skin issues) when in the US.

    His particular focus is understanding what matters most to his patients and how his patients' skin issues affect their quality of life. To help him, Dr. Secrest encourages his patients to complete a quality of life assessment called Skindex-16 at every visit. Skindex-16 asks questions to help Dr. Secrest and his patients understand how their skin issues are affecting their symptoms, their emotions, and their ability to function. Skindex-16 is particularly useful because it helps Dr. Secrest track how his patients feel their skin issues are doing - are they getting better or worse over time His patients can request copies of their Skindex-16 scores at any time to see how they are doing.

    Dr. Secrest completed an MBA in 2020 at the University of Utah to help him understand the business side of medicine to try to find ways to help improve how healthcare works in the U.S. Dr. Secrest is keenly aware of how insurances are changing over the years, and often, patients are required to pay for more of their care and their treatments out-of-pocket. Dr. Secrest spends time trying to identify the most cost-effective care for his patients, even if that means the best treatment is over-the-counter. Please let Dr. Secrest know if you have a high-deductible plan, so he can ensure you get the best value out of your care.

    Dr. Secrest recently stepped down as Vice Chair of Business Strategy for Dermatology but remains as an Adjunct Assistant Professor in the Departments of Dermatology and Population Health Sciences at the University of Utah, where, in addition to seeing patients, he does research on quality of life, access to care, and costs of care in dermatology. He is board-certified in dermatology and a member of both the American Academy of Dermatology and the Society for Pediatric Dermatology. He completed an intern year at Cincinnati Children's Hospital prior to his dermatology training at the University of Utah, where he served as a chief resident.

    Specialties

    Board Certification

    American Board of Dermatology

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 46 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Now officially my favorite provider.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    I will rate him up there with the top five doctors that I've ever had the pleasure of being with. I would call it a great bedside manner.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr Secrest is genuine, kind, & compassionate, everything a doctor should be. I can only tell you amazing things about him.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr. Secrest is one of the kindest most reassuring doctors I have ever seen. His professional skills are excellent, of course, but his good humor and kindness set him apart. He's outstanding in every way!

    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    Dr. Secrest was as spectacular as Dr. Sonnheimer.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr. Secrest was absolutely amazing. He might be my all time favorite doctor.

    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    Dr Secrest is absolutely the best dermatologist I've ever been to. He's personable, kind, relatable and doesn't make you uncomfortable in any way when discussing issues.

    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    excellent dr and staff! above and beyond!! helpful, knowledgeable, and kind. love them

    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    good

  • Aaron Secrest, MD, PhD, MBA, is currently on a two-year sabbatical working as a senior medical officer in dermatology at Christchurch Hospital in New Zealand to experience a quality national healthcare system firsthand. He is temporarily stepping away from routine clinical care at Farmington Health Center and the University Hospital outpatient clinic. He will continue to staff Rapid Access Dermatology clinic (urgent care for skin issues) when in the US.

    His particular focus is understanding what matters most to his patients and how his patients' skin issues affect their quality of life. To help him, Dr. Secrest encourages his patients to complete a quality of life assessment called Skindex-16 at every visit. Skindex-16 asks questions to help Dr. Secrest and his patients understand how their skin issues are affecting their symptoms, their emotions, and their ability to function. Skindex-16 is particularly useful because it helps Dr. Secrest track how his patients feel their skin issues are doing - are they getting better or worse over time His patients can request copies of their Skindex-16 scores at any time to see how they are doing.

    Dr. Secrest completed an MBA in 2020 at the University of Utah to help him understand the business side of medicine to try to find ways to help improve how healthcare works in the U.S. Dr. Secrest is keenly aware of how insurances are changing over the years, and often, patients are required to pay for more of their care and their treatments out-of-pocket. Dr. Secrest spends time trying to identify the most cost-effective care for his patients, even if that means the best treatment is over-the-counter. Please let Dr. Secrest know if you have a high-deductible plan, so he can ensure you get the best value out of your care.

    Dr. Secrest recently stepped down as Vice Chair of Business Strategy for Dermatology but remains as an Adjunct Assistant Professor in the Departments of Dermatology and Population Health Sciences at the University of Utah, where, in addition to seeing patients, he does research on quality of life, access to care, and costs of care in dermatology. He is board-certified in dermatology and a member of both the American Academy of Dermatology and the Society for Pediatric Dermatology. He completed an intern year at Cincinnati Children's Hospital prior to his dermatology training at the University of Utah, where he served as a chief resident.

    Board Certification and Academic Information

    Academic Departments Dermatology -Adjunct Assistant Professor
    Population Health Sciences -Adjunct Assistant Professor
    Board Certification
    American Board of Dermatology

    Education history

    Undergraduate Major: Microbiology: Minors: Asian Studies, Business Management - Brigham Young University B.S.
    Professional Medical Medicine - University of Pittsburgh M.D.
    Graduate Training Epidemiology - University of Pittsburgh M.P.H.
    Doctoral Training Epidemiology - University of Pittsburgh Ph.D.
    Internship/Residency Pediatrics - Cincinnati Children¿s Hospital Medical Center Intern/Resident
    Residency Dermatology - University of Utah School of Medicine Resident
    Chief Resident Dermatology - University of Utah School of Medicine Chief Resident
    Graduate Training Eccles School of Business - University of Utah M.B.A.

    Selected Publications

    Journal Article

    1. Andrulonis R, Secrest AM, McGuire ST, Geskin LJ, Ferris LK (2010). The influence of age and sex on reasons for seeking and expected benefits of skin cancer screening. Arch Dermatol, 146(10), 1097-102. (Read full publication)
    2. McGuire ST, Secrest AM, Andrulonis R, Ferris LK (2011). Surveillance of patients for early detection of melanoma: patterns in dermatologist vs patient discovery. Arch Dermatol, 147(6), 673-8. (Read full publication)
    3. Hopkins ZH, Secrest A (2019). Public Health Implications of Google Searches for Sunscreen, Sunburn, Skin Cancer, and Melanoma in the United States. American journal of health promotion, 33(4), 611-615. (Read full publication)
    4. Hopkins ZH, Moreno C, Secrest A (2019). Lack of confidence interval reporting in dermatology: a call to action. The British journal of dermatology, 180(4), 910-915. (Read full publication)
    5. Gaufin M, Hess R, Hopkins ZH, Biber JE, Secrest A (2020). Practical screening for depression in dermatology: using technology to improve care. The British journal of dermatology, 182(3), 786-787. (Read full publication)
    6. Hopkins ZH, Secrest A (2019). An international comparison of Google searches for sunscreen, sunburn, skin cancer, and melanoma: Current trends and public health implications. Photodermatology, photoimmunology & photomedicine, 35(2), 87-92. (Read full publication)
    7. Taliercio VL, Snyder AM, Biggs AM, Kean J, Hess R, Duffin KC, Cizik AM, Secrest A (2021). Clinicians' perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. Quality of life research, 31(6), 1719-1725. (Read full publication)
    8. Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard T (2011). Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study. Annals of epidemiology, 21(5), 367-73. (Read full publication)
    9. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard T (2011). Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries. Diabetic medicine, 28(3), 293-300. (Read full publication)
    10. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard T (2010). Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes, 59(12), 3216-22. (Read full publication)
    11. Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard T (2012). Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes, 61(11), 2987-92. (Read full publication)
    12. Orchard TJ, Secrest AM, Miller RG, Costacou (2010). In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia, 53(11), 2312-9. (Read full publication)
    13. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard T (2010). All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes care, 33(12), 2573-9. (Read full publication)
    14. Clark JJ, Secrest AM, Hull CM, Eliason MJ, Leiferman KM, Gleich GJ, Powell D (2016). The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review. Journal of the American Academy of Dermatology, 74(6), 1274-6. (Read full publication)
    15. Andrulonis R, Secrest AM, Patton TJ, Grandinetti LM, Ferris L (2017). A cross-sectional study of indoor tanning use among patients seeking skin cancer screening. Journal of the American Academy of Dermatology, 76(1), 164-165. (Read full publication)
    16. Secrest AM, Asgari MM, Kourosh AS, Barbieri JS, Albrecht (2017). Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff. Journal of the American Academy of Dermatology, 77(4), 784-786. (Read full publication)
    17. Matsumoto M, Secrest A, Anderson A, Saul MI, Ho J, Kirkwood JM, Ferris L (2018). Estimating the cost of skin cancer detection by dermatology providers in a large health care system. Journal of the American Academy of Dermatology, 78(4), 701-709.e1. (Read full publication)
    18. Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright L (2018). Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011). Journal of the American Academy of Dermatology, 79(2), 238-244. (Read full publication)
    19. Taliercio V, Langner AU, Secrest AM, Duffin K (2021). Assessing psoriasis severity: psychometric validation of overall physician global assessment (OPGA). Journal of the American Academy of Dermatology, 86(3), 637-638. (Read full publication)
    20. Clark JJ, Snyder AM, Sreekantaswamy SA, Petersen MJ, Lewis BKH, Secrest AM, Florell S (2021). Dermatologic care of incarcerated patients: A single-center descriptive study of teledermatology and face-to-face encounters. Journal of the American Academy of Dermatology, 85(6), 1660-1662. (Read full publication)
    21. Strunck JL, Smart TC, Boucher KM, Secrest AM, Grossman (2020). Improved melanoma outcomes and survival in patients monitored by total body photography: A natural experiment. The Journal of dermatology, 47(4), 342-347. (Read full publication)
    22. Flint ND, Rhoads JLW, Carlisle R, Ferrel M, Hopkins ZH, Secrest A (2021). The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone. Dermatology online journal, 27(8), (Read full publication)
    23. Flint ND, Bishop MD, Smart TC, Strunck JL, Boucher KM, Grossman D, Secrest A (2021). Low accuracy of self-reported family history of melanoma in high-risk patients. Familial cancer, 20(1), 41-48. (Read full publication)
    24. Hopkins ZH, Moreno C, Secrest A (2020). Influence of Social Media on Cosmetic Procedure Interest. The Journal of clinical and aesthetic dermatology, 13(1), 28-31. (Read full publication)
    25. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest A (2021). The Disruptiveness of Itchiness from Psoriasis: A Qualitative Study of the Impact of a Single Symptom on Quality of Life. The Journal of clinical and aesthetic dermatology, 14(6), 42-48. (Read full publication)
    26. Flint ND, Simister S, Secrest A (2021). Usefulness of an Inexpensive, Battery-Powered, Handheld Microscope in Low-Resource Dermatologic Practices. Indian dermatology online journal, 12(4), 645-646. (Read full publication)
    27. Saluja SS, Secrest AM, Florell S (2016). Acute Presentation of Tender Papules and Plaques in a Patient With Leukemia. JAMA dermatology, 152(5), 571-2. (Read full publication)
    28. Houston NA, Secrest AM, Harris RJ, Mori WS, Eliason MJ, Phillips CM, Ferris L (2016). Patient Preferences During Skin Cancer Screening Examination. JAMA dermatology, 152(9), 1052-4. (Read full publication)
    29. Anderson AM, Matsumoto M, Saul MI, Secrest AM, Ferris L (2018). Accuracy of Skin Cancer Diagnosis by Physician Assistants Compared With Dermatologists in a Large Health Care System. JAMA dermatology, 154(5), 569-573. (Read full publication)
    30. Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE, Chen SC, Chren MM, Ferris LK, Kean J, Hess R, Dermatology PRO Consortium (2020). Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin Treatment. JAMA dermatology, 156(10), 1098-1106. (Read full publication)
    31. Carlisle RP, Flint ND, Hopkins ZH, Eliason MJ, Duffin KC, Secrest A (2020). Administrative Burden and Costs of Prior Authorizations in a Dermatology Department. JAMA dermatology, 156(10), 1074-1078. (Read full publication)
    32. Kennedy J, Arey S, Hopkins Z, Tejasvi T, Farah R, Secrest AM, Lipoff J (2021). Dermatologist Perceptions of Teledermatology Implementation and Future Use After COVID-19: Demographics, Barriers, and Insights. JAMA dermatology, 157(5), 595-597. (Read full publication)
    33. Anderson A, Matsumoto M, Secrest A, Saul MI, Ho J, Ferris L (2021). Cost of Treatment of Benign and Premalignant Lesions During Skin Cancer Screening. JAMA dermatology, 157(7), 876-879. (Read full publication)
    34. Laggis CW, Secrest AM, Agyei M, Simister S, Davis AN, Dickerson T, Rhoads J (2020). The Impact of Skin Disease on Quality of Life in Rural Communities of Ghana. 4(5), 417-423.
    35. Ma B, Sahni V, Sahni D, Secrest (2021). Disseminate and Recurrent Infundibulofolliculitis: An Under-Recognized Yet Treatable Entity. Journal of drugs in dermatology, 20(12), 1353-1354. (Read full publication)
    36. Hopkins ZH, Carlisle RP, Frost ZE, Curtis JA, Ferris LK, Secrest A (2021). Risk Factors and Predictors of Survival Among Patients with Amelanotic Melanoma Compared to Melanotic Melanoma in the National Cancer Database. The Journal of clinical and aesthetic dermatology, 14(12), 36-43. (Read full publication)
    37. Secrest AM, Chren M (2022). Incorporating patient-reported outcomes as a vital sign for dermatologic clinical care and clinical investigations. The Journal of investigative dermatology, 142, 1529-1532. (Read full publication)
    38. Sahni VN, Dao DP, Sahni DR, Secrest A (2021). Lichen spinulosus: insights into treatment. Dermatology online journal, 27(10), (Read full publication)
    39. Snyder AM, Brandenberger AU, Taliercio VL, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest A (2022). Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis. International journal of behavioral medicine, 30(3), 409-415. (Read full publication)
    40. Amanullah AA, Sahni DR, Sahni VN, Hull CM, Powell DL, Secrest A (2022). Reply to: current treatment modalities in granulomatous cheilitis. International journal of dermatology, (Read full publication)
    41. Elkeeb DM, Hopkins ZH, Bolender CM, Moreno C, Florell SR, Bowen AR, Vitale P, Zussman J, Duffy K, Grossman D, Secrest AM, Wada D (2023). A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management. The American Journal of dermatopathology, 45(1), 28-39. (Read full publication)
    42. Hopkins ZH, Kuceki G, Taliercio VL, Snyder AM, Stoddard GJ, Duffin KC, Hess R, Secrest A (2022). Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance. Archives of dermatological research, (Read full publication)
    43. Kern JA, Amanullah AA, Sahni DR, Mathis JG, Hull CM, Powell DL, Secrest A (2023). Granulomatous cheilitis - is there a role for allergen screening and avoidance?. The Journal of dermatological treatment, 34(1), 1-3. (Read full publication)
    44. Snyder AM, Chen SC, Chren MM, Ferris LK, Edwards LD, Swerlick RA, Flint ND, Cizik AM, Hess R, Kean J, Secrest AM, Dermatology PRO Consortiu (2023). Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology. American journal of clinical dermatology, 24(4), 1-13. (Read full publication)
    45. Kuceki G, Snyder AM, Hopkins ZH, Secrest A (2023). A survey of United States dermatologists' knowledge, attitudes, and practices with intramuscular triamcinolone. Archives of dermatological research, (Read full publication)
    46. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest A (2023). Atopic Dermatitis: A Qualitative Study on the Burdens of Living with Itchiness. The Journal of clinical and aesthetic dermatology, 16(7), 22-25. (Read full publication)
    47. Hopkins Z, Diaz O, Kaprive JF, Carlisle R, Moreno C, Bommareddy K, Sheikh N, Frost Z, Akhtar A, Secrest A (2023). Methods Reporting Quality and its Association with Methods Section Length: A Cross-sectional Assessment of STROBE and CONSORT Reporting Adherence in Top-cited Dermatology Journals. The Journal of clinical and aesthetic dermatology, 16(7), 54-62. (Read full publication)
    48. Simister S, Flint N, Webb J, Nyarko O, Secrest A, Lewis B, Dickerson (2023). Exploring the knowledge, attitude, and practices of over-the-counter medical sellers in Ghana. Journal of public health in Africa, 14(4), 2122. (Read full publication)
    49. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest A (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA dermatology, 159(11), 1185-1194. (Read full publication)
    50. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Biber JE, Hess R, Rhoads JL, Secrest A (2023). Quality of Life and Avoiding Triggers of Atopic Dermatitis Flares: A Qualitative Study. Skinmed, 21(4), 233-235. (Read full publication)
    51. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest A (2021). Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families. JMIR dermatology, 4(2), e29826. (Read full publication)
    52. Kuceki G, Deacon DC, Secrest A (2022). Amelanotic Melanoma Treated as Fungal Infection for Years. Case reports in dermatological medicine, 2022, 2598965. (Read full publication)
    53. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JL, Secrest A (2022). Why so Blue? (Or Should I Say Red?) Recognizing the Emotional Impact of Psoriasis on Patients and Family Members: A Qualitative Study. Journal of psoriasis and psoriatic arthritis, 7(2), 60-66. (Read full publication)
    54. Snyder AM, Taliercio VL, Webber LB, Brandenberger AU, Rich BE, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest A (2022). The Role of Pain in the Lives of Patients with Psoriasis: A Qualitative Study on an Inadequately Addressed Symptom. Journal of psoriasis and psoriatic arthritis, 7(1), 29-34. (Read full publication)

    Review

    1. Collins MK, Secrest AM, Ferris L (2014). Screening for melanoma. Melanoma research, 24(5), 428-36. (Read full publication)
    2. Thomas LW, Elsensohn A, Bergheim T, Shiu J, Ganesan A, Secrest (2018). Intramuscular Steroids in the Treatment of Dermatologic Disease: A Systematic Review. Journal of drugs in dermatology, 17(3), 323-329. (Read full publication)
    3. Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, Secrest AM, Washington RE, Orchard T (2018). Mortality in Type 1 Diabetes. (Read full publication)

    Book Chapter

    1. Secrest AM, Washington RE, Orchard T (2017). Chapter 35. Mortality in type 1 diabetes. 35.1-35.16.

    Editorial

    1. Secrest AM, Coman GC, Swink JM, Duffy K (2021). Limiting Residency Applications to Dermatology Benefits Nearly Everyone. The Journal of clinical and aesthetic dermatology, 14(7), 30-32. (Read full publication)
    2. Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren M (2018). How data can deliver for dermatology. 79(2), 400-402.
    3. Hopkins ZH, Han G, Tejasvi T, Deda LC, Goldberg R, Kennedy J, Arey S, Mathis JG, Balk R, Miller J, Secrest AM, Farah R, Lipoff J (2022). Teledermatology During the COVID-19 Pandemic: Lessons Learned and Future Directions. Cutis, 109(1), 12-13. (Read full publication)

    Letter

    1. Secrest AM, Chren MM, Hopkins ZH, Chen SC, Ferris LK, Hess (2019). Benefits to patient care of electronically capturing patient-reported outcomes in dermatology. The British journal of dermatology, 181(4), 826-827. (Read full publication)
    2. Truong A, Secrest AM, Fino NF, Laggis CW, Lewis BK (2020). Homeless status and associations with treatment disparities for common skin conditions. The British journal of dermatology, 183(3), 582-584. (Read full publication)
    3. Ma BC, Sahni VN, Edwards LD, Sahni DR, Secrest A (2021). Response to 'A call to standardize the BCC:SCC ratio'. The British journal of dermatology, 185(4), 868-869. (Read full publication)
    4. Jensen NC, Snyder AM, Secrest AM, Mathis J (2021). Retrospective review of IVIG use and cutaneous lupus in inflammatory autoimmune neuropathies: a case-cohort study. International journal of dermatology, 61, e445-e447. (Read full publication)
    5. Truong A, Laggis CW, Annis TD, Secrest AM, Fino NF, Powell DL, Gardner LJ, Gregory T, Hull CM, Lewis BK (2020). Factors associated with follow-up adherence in patients seen at a referral-based dermatology clinic for the homeless. Journal of the American Academy of Dermatology, 83(2), 629-631. (Read full publication)
    6. Truong A, Secrest AM, Zhang M, Forbes BR, Laggis CW, McFadden M, Gardner LJ, Powell DL, Lewis BK (2021). A survey of dermatologic health-related quality of life and resource access in patients experiencing homelessness. Journal of the American Academy of Dermatology, 85(3), 775-778. (Read full publication)
    7. Secrest AM, Elkeeb DM, Petron B, Elsensohn A, Edwards LD, Krueger GG, Duffin K (2019). Systemic corticosteroid use in psoriasis: a national survey of board-certified dermatologists. Journal of the European Academy of Dermatology and Venereology, 33(3), e116-e117. (Read full publication)
    8. Laggis CW, Lamb A, Secrest AM, Ufkes N, Halwani AS, Tao R, Gaffney D, Miles RR, Florell SR, Wada (2021). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution. Journal of the European Academy of Dermatology and Venereology, 35(1), e42-e45. (Read full publication)
    9. Ali NS, Sahni VN, Ma BC, Sahni DR, Hull CM, Powell DL, Secrest A (2021). Reply to: low response of granulomatous cheilitis to currently established treatments. Journal of the European Academy of Dermatology and Venereology, 35(12), e930-e931. (Read full publication)
    10. Stone CJ, Ufkes N, Secrest AM, Murtaugh MA, Vanneman ME, Snyder A (2025). Relationships Between Quality of Life and Emotional Resilience for Those With and Without Acne. Journal of cosmetic dermatology, 24(1), e16744. (Read full publication)

  • News & Podcasts

    News